Preclinical Characterization of PRT1419, a Potent, Selective and Orally Bioavailable Inhibitor of MCL1

Neha Bhagwat, Alexander Grego, William Gowen-MacDonald, Min Wang, Miles Cowart, Xiaowei Wu, Dave Rominger, Joseph Rager, Tom Emm, Venkat Thodima, Raul Leal, Karl Blom, Jincong Zhuo, Andrew Combs, Bruce Ruggeri, Peggy Scherle, Kris Vaddi. AACR Annual Meeting 2021; April 10-15, 2021.